Outcome of Platelets Rich Plasma (PRP) in Treatment of Plantar Fasciitis
Abstract
Objective: To determine the effectiveness of Platelet-rich plasma (PRP) in the treatment of Plantar fasciitis.
METHODOLOGY: A Quasi-experimental study was conducted at the Department of Orthopedics,
Ward-17, JPMC, Karachi, from July 2018 to June 2019. Diagnosed cases of plantar fasciitis, age ranging from 20-60 years, both genders, with failed conservative treatment of 3 months willing to undergo treatment with PRP injection were included. Patients with a previous history of calcaneal fractures, infection, osteoarthritis of currently affected limbs, skin wounds or lesions, diabetes mellitus and other causes of heel pain were excluded. The selection was made from the outdoor department, and intervention was done as a daycare procedure. Two-three ml of centrifuged PRP was injected into the heel. Patients were followed up at 1, 3 and 6-month intervals post-procedure. Findings were recorded on a predesigned proforma VAS, and Roles and Maudsley scoring was done. Data analysis was done using SPSS version 21.
Results: Two hundred and ninety-five patients were enrolled in the study. There were 5 (1.69%) males and 290 (98.3%) females. 100 (33.89%) patients were between 20-40 years. 195 (66.10%) patients were between 41-60 years. By 3rd follow-up visit, i.e., six months post-intervention, excellent results were obtained in 149 (50.5%) patients. 136 (46.1%) showed good (VAS = 1 to 4) results, 07 (2.37%) had acceptable (VAS = 4 to 6) results and 03 (1.01%) had poor (VAS ? 7) results.
Conclusion: The present study reported that Platelet-rich plasma (PRP) injection successfully improved pain symptoms in most patients, with at least half of the population reporting excellent outcomes.
Keywords: Inflammation, Platelet-rich plasma, Plantar fasciitis.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.